propranolol has been researched along with B16 Melanoma in 5 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol treatment delayed primary tumor growth and metastases development in MT/Ret mice." | 1.43 | Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma. ( Bod, L; Jean Wrobel, L; Kato, M; Le Gal, FA; Lengagne, R; Prévost-Blondel, A, 2016) |
| " On the contrary, the chronic administration of corticosterone significantly induced the atrophy of thymus and spleen without affecting tumor growth." | 1.31 | Psychosocial stress augments tumor development through beta-adrenergic activation in mice. ( Hasegawa, H; Saiki, I, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, GH | 1 |
| Liu, J | 1 |
| Zhang, J | 1 |
| Wang, Y | 1 |
| Peng, XC | 1 |
| Wei, YQ | 1 |
| Jiang, Y | 1 |
| Xiao, R | 1 |
| Bergin, SM | 1 |
| Huang, W | 1 |
| Slater, AM | 1 |
| Liu, X | 1 |
| Judd, RT | 1 |
| Lin, ED | 1 |
| Widstrom, KJ | 1 |
| Scoville, SD | 1 |
| Yu, J | 1 |
| Caligiuri, MA | 1 |
| Cao, L | 1 |
| Jean Wrobel, L | 1 |
| Bod, L | 1 |
| Lengagne, R | 1 |
| Kato, M | 1 |
| Prévost-Blondel, A | 1 |
| Le Gal, FA | 1 |
| Glasner, A | 1 |
| Avraham, R | 1 |
| Rosenne, E | 1 |
| Benish, M | 1 |
| Zmora, O | 1 |
| Shemer, S | 1 |
| Meiboom, H | 1 |
| Ben-Eliyahu, S | 1 |
| Hasegawa, H | 1 |
| Saiki, I | 1 |
5 other studies available for propranolol and B16 Melanoma
| Article | Year |
|---|---|
Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model.
Topics: Adrenergic alpha-Agonists; Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Drug Screening Assays | 2014 |
Environmental and Genetic Activation of Hypothalamic BDNF Modulates T-cell Immunity to Exert an Anticancer Phenotype.
Topics: Adrenergic beta-Antagonists; Animals; Brain-Derived Neurotrophic Factor; CD8-Positive T-Lymphocytes; | 2016 |
Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Lymphocytes, Tumor-Infiltrating; Melanoma, Exper | 2016 |
Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor.
Topics: Adrenergic beta-Antagonists; Amputation, Surgical; Animals; Antineoplastic Combined Chemotherapy Pro | 2010 |
Psychosocial stress augments tumor development through beta-adrenergic activation in mice.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Cell Division; | 2002 |